Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Some topical treatments like corticosteroids and vitamin D analogues are effective for scalp psoriasis, but more long-term data is needed.

Arabidopsis PCaP2 helps plants survive drought by linking ABA and SA signals.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Most skin care products are safe during pregnancy, but avoid hydroquinone and tretinoin.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

The method accurately measures 19 steroid hormones in human blood and urine using a small sample and is suitable for large-scale monitoring.

Rice husk and bran extracts from the Bue Bang 3 CMU variety can potentially treat hair loss due to their antioxidant, anti-inflammatory, and anti-androgenic properties.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Mogamulizumab can cause hair loss and skin rashes.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.

A woman lost all her hair after mild COVID-19, but it started to regrow after treatment with a specific medication.

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

A new AI model diagnoses hair and scalp disorders with 92% accuracy, better than previous models.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.